Essay answer on sinonasal undifferentiated carcinoma

Reading File
Finding Sources
Finding Sources
Searching PubMed

"sinonasal undifferentiated carcinoma"

Reading File
Reading File
Reading Article

PMID: 39162231

Reading Article

PMID: 39489553

Finding Sources
Reading File
Finding Sources
Reading File
I now have comprehensive material. Let me write the essay.

Sinonasal Undifferentiated Carcinoma (SNUC)

Introduction

Sinonasal undifferentiated carcinoma (SNUC) is a rare, highly aggressive malignant epithelial neoplasm of the nasal cavity and paranasal sinuses. It was first recognised as a distinct clinicopathological entity by Mills and colleagues in 1987 and is defined by the absence of squamous, glandular, or neuroendocrine differentiation on light microscopy. Because of its rarity, most clinical data derive from retrospective series spanning decades and small institutional cohorts. Despite multimodal treatment advances, SNUC carries one of the worst prognoses among all sinonasal malignancies.

Epidemiology and Aetiology

SNUC is exceedingly rare, accounting for fewer than 5% of all sinonasal malignancies. It shows a male predominance (approximately 2:1) and most commonly presents in the fifth to sixth decade of life. Unlike sinonasal squamous cell carcinoma (SCC), there is no established causative link with occupational exposures (e.g., nickel, chromium, hardwood dust), tobacco, or EBV infection. The aetiology remains largely unknown.
Recent genomic studies have substantially reshaped the classification of undifferentiated sinonasal tumours. Several molecularly distinct entities — previously grouped under the SNUC umbrella — have been delineated, including:
  • IDH2-mutant SNUC — carries somatic IDH2 hotspot mutations and a distinctive histomorphology
  • SMARCA4-deficient (INI-1-deficient) sinonasal carcinoma — loss of SWI/SNF chromatin remodelling complex subunit
  • NUT (nuclear protein in testis) midline carcinoma — defined by NUT gene rearrangement, extremely aggressive
  • SMARCB1-deficient sinonasal carcinoma
This means that historical series may actually describe heterogeneous tumour populations, complicating interpretation of outcomes data. Modern pathological re-review with molecular profiling is therefore essential — Cummings Otolaryngology Head and Neck Surgery explicitly notes that retrospective series "often span decades" and, without re-review, "may describe multiple distinct tumour types."

Pathology

Gross Features

Tumours are bulky, fleshy masses that are locally destructive and frequently involve multiple sinonasal subsites simultaneously at presentation. The nasal cavity, ethmoid sinuses, and maxillary sinuses are the most common primary sites.

Histology

SNUC is composed of small round blue cells arranged in nests, sheets, trabeculae, or ribbons with prominent necrosis and high mitotic activity. There is no squamous pearl formation, mucin production, or Homer Wright rosette formation. Pleomorphism is moderate to marked.

Immunohistochemistry (IHC)

The IHC profile distinguishes SNUC from related small round cell tumours:
MarkerSNUCENBSNEC
Cytokeratin (CK)PositiveNegativePositive
EMAPositiveFocalPositive
NSEWeak positivePositivePositive
Chromogranin/SynaptophysinNegativeStrongly positivePositive (diffuse)
S100NegativePositive (sustentacular)Variable
p63/p40NegativeNegativeNegative
— K.J. Lee's Essential Otolaryngology
SNUC is thus characterised as CK+, EMA+, weakly NSE+, and negative for neuroendocrine markers (chromogranin, synaptophysin). This profile is critical to separate it from esthesioneuroblastoma (ENB) and sinonasal neuroendocrine carcinoma (SNEC).

Differential Diagnosis

The main entities to exclude are:
  1. Esthesioneuroblastoma (ENB) — CK negative, S100-positive sustentacular cells, Homer Wright rosettes
  2. Sinonasal neuroendocrine carcinoma (SNEC) — CK positive but diffusely expresses neuroendocrine markers
  3. NUT carcinoma — requires FISH or IHC for NUT protein; extremely aggressive
  4. Lymphoma — CD45+, CK negative
  5. Rhabdomyosarcoma — desmin, myogenin positive
  6. Mucosal melanoma — HMB-45, Melan-A, S100 positive
  7. Nasopharyngeal carcinoma (NPC) — EBV-encoded RNA (EBER) in situ hybridisation positive; frequently involves the nasopharynx
A 2024 review by Tandon & Kakkar (Surg Pathol Clin, PMID 39489553) emphasises that "histologic features overlap with each other and with other sinonasal neoplasms," and that IHC, in situ hybridisation, and molecular testing are all necessary to arrive at a final diagnosis.

Clinical Features

SNUC typically presents at an advanced stage (80% are T4 at presentation per meta-analysis data). Symptoms are non-specific and include:
  • Unilateral nasal obstruction and epistaxis (most common)
  • Facial pain and swelling
  • Proptosis, diplopia, epiphora — orbital involvement
  • Trismus — pterygoid/infratemporal involvement
  • Cranial nerve palsies — skull base involvement (CN II, V, VI)
  • Headache — intracranial extension
Because these symptoms overlap with chronic sinusitis, diagnosis is frequently delayed.

Staging

SNUC is staged using the AJCC/UICC TNM staging system for paranasal sinus or nasal cavity primaries, depending on the site of origin. The majority of patients present with T4 disease (erosion of skull base, orbit, pterygoid plates, anterior cranial fossa, or dura):
  • T1 — confined to one subsite of the nasal cavity/paranasal sinus, without bony erosion
  • T2 — extension to adjacent subsite or adjacent region
  • T3 — extension to medial orbital floor/wall, maxillary sinus, palate, cribriform plate
  • T4a — anterior skull base, orbital contents, pterygoid plates, frontal/sphenoid sinuses (moderately advanced)
  • T4b — orbital apex, dura, brain, CN involvement (very advanced)
Regional (cervical) nodal involvement is seen in 10–30% at presentation, and distant metastases (lungs, bone, liver) are common.

Imaging

CT

CT is essential for delineating bony destruction. Findings typically show an aggressive soft-tissue mass with extensive bone erosion across multiple sinuses, commonly involving the skull base.

MRI

MRI is superior for assessing soft-tissue extent — orbital, dural, and brain invasion. SNUC typically shows:
  • Intermediate T1 signal
  • Intermediate-to-low T2 signal (hypercellular tumour)
  • Avid heterogeneous enhancement
  • Restricted diffusion on DWI (high cellularity → low apparent diffusion coefficient / ADC)
Cummings Otolaryngology notes that ADC on DWI is useful in characterising sinonasal neoplasms; highly cellular malignant tumours like SNUC show low ADC values.

PET-CT

PET-CT is valuable for staging regional nodes (including retropharyngeal nodes), detecting occult distant metastases, and assessing treatment response.

Management

Given the rarity of SNUC, there are no prospective randomised trials. Management is based on retrospective series, institutional protocols, and meta-analyses, and should always occur in a multidisciplinary setting.

Surgery

Complete gross surgical resection confers the best local control. In a UCSF series, 5-year local control was 74% for gross total resection vs. 24% for subtotal resection — a stark difference underscoring the importance of achieving negative margins (Cummings Otolaryngology Head and Neck Surgery).
Surgical approaches include:
  • Craniofacial resection (CFR) — the historical gold standard; combined transfacial + frontal craniotomy allows en-bloc resection of the skull base and dura, with pericranial flap reconstruction. Mortality ~4.7%, morbidity 33–36%
  • Endoscopic endonasal approach (EEA) — now increasingly used; avoids facial incisions and craniotomy, offers excellent magnification. Suitable for select cases without significant orbital or lateral skull base extension

Radiation Therapy

Radiation forms an essential component of treatment. IMRT is the standard technique, allowing conformal high-dose delivery while sparing adjacent structures (optic apparatus, brainstem, temporal lobes).
Proton beam therapy offers a dosimetric advantage in skull base lesions by reducing integral dose to surrounding critical structures, though survival equivalence over IMRT is not definitively established for SNUC.

Chemotherapy

SNUC is chemosensitive. Platinum-based regimens (cisplatin ± 5-fluorouracil; or cisplatin + etoposide) are used in:
  1. Induction (neoadjuvant) chemotherapy — followed by concurrent chemoradiation or surgery
  2. Concurrent chemoradiation — for unresectable disease or organ preservation
A landmark 2024 meta-analysis by Burggraf et al. (Head Neck, PMID 39162231) — analysing 192 patients with individual patient data — demonstrated 5-year OS of 72.6% in patients receiving induction chemotherapy vs. 44.5% without induction chemotherapy, concluding that "IC should be considered in every patient diagnosed with SNUC."

Trimodality Therapy

Multiple studies support trimodality therapy (induction chemotherapy + chemoradiation + surgery) as the most effective approach:
  • Rischin et al. reported 2-year OS of 64% with induction platinum/5-FU followed by concurrent platinum-based chemoRT
  • Rosenthal et al. (MD Anderson) reported 5-year OS of 64.2% with combination therapy
  • Mourad et al. (18 patients) found improved local control and freedom from distant metastasis with trimodality vs. single/dual modality
  • Morand et al. meta-analysis (29 series, 390 patients): single modality was associated with nearly 3-fold increased risk of death (HR 2.97 vs. dual modality; HR 2.80 vs. triple modality). Best outcomes with surgery + radiation.
The optimal sequencing (induction → CRT → surgery vs. upfront surgery → adjuvant CRT) remains debated and is influenced by resectability and patient performance status.

Neck Management

Elective neck treatment is warranted even in clinically N0 patients given the significant risk of regional failure. The Morand meta-analysis found 27% of patients experienced regional failure at 2 years. Elective neck irradiation (to ~50 Gy equivalent) is generally incorporated into radiotherapy planning.

Prognosis

SNUC carries a dismal prognosis when treated with single-modality therapy:
  • An international collaborative study of 344 patients reported 5-year OS of 0% for undifferentiated tumours (n=14)
  • The University of Michigan experience: 5-year OS of 22%
  • With aggressive multimodal treatment, 5-year OS approaches 44–65% in modern series
  • Burggraf et al. 2024 meta-analysis: pooled 5-year OS of 43.8% across 13 studies
Principal modes of failure are:
  1. Locoregional recurrence — especially in incompletely resected or unresected disease
  2. Distant metastases — lungs, bone, liver; common even after local control
Adverse prognostic factors include advanced T stage, skull base/dural invasion, nodal metastasis, incomplete resection, and absence of chemotherapy.

Special Considerations: Molecular Subtypes and IDH2

The recognition of IDH2-mutant SNUC is clinically important: IDH2 mutations are targetable with inhibitors (e.g., enasidenib). These tumours may have a more favourable biology. Molecular profiling of all newly diagnosed SNUC cases is increasingly recommended to identify actionable alterations and to enable correct diagnosis within the spectrum of sinonasal undifferentiated/poorly differentiated carcinomas.

Summary

SNUC is a rare, highly lethal sinonasal malignancy characterised by:
  • Presentation at advanced stage with extensive local destruction and high distant metastasis risk
  • Small round blue cell histology; CK+, EMA+, neuroendocrine marker negative
  • Mandatory exclusion of ENB, SNEC, NUT carcinoma, and other small round cell tumours via IHC and molecular testing
  • Treatment with multimodal therapy — induction chemotherapy is strongly supported by the 2024 meta-analysis as improving survival
  • 5-year OS of ~44–73% with modern multimodal approaches, versus near-zero with single-modality treatment
  • Emerging molecular classification (IDH2, SMARCA4, NUT gene rearrangement) reshaping nosology and opening targeted therapy avenues

Key References:
  • Cummings Otolaryngology Head and Neck Surgery (pp. 2277–2278, Skull Base chapter)
  • K.J. Lee's Essential Otolaryngology (10th ed., pp. 593, 599)
  • Burggraf M et al. Head Neck. 2024 — Meta-analysis; IC significantly improves 5-year OS (72.6% vs. 44.5%) [PMID: 39162231]
  • Tandon A, Kakkar A. Surg Pathol Clin. 2024 — Molecular classification update [PMID: 39489553]

Can you please make this into pdf

Reading File
Running Command

ls -la /home/daytona/workspace/

Running Command

mkdir -p /home/daytona/workspace/snuc-essay

Writing File

~/snuc-essay/generate_pdf.py

from reportlab.lib.pagesizes import A4
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.units import cm
from reportlab.lib import colors
from reportlab.platypus import (
    SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, HRFlowable, KeepTogether
)
from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY

OUTPUT = "/home/daytona/workspace/snuc-essay/SNUC_Essay.pdf"

doc = SimpleDocTemplate(
    OUTPUT,
    pagesize=A4,
    leftMargin=2.5*cm,
    rightMargin=2.5*cm,
    topMargin=2.5*cm,
    bottomMargin=2.5*cm,
    title="Sinonasal Undifferentiated Carcinoma",
    author="Orris Medical",
)

styles = getSampleStyleSheet()

# Custom styles
title_style = ParagraphStyle(
    "CustomTitle",
    parent=styles["Title"],
    fontSize=20,
    leading=26,
    textColor=colors.HexColor("#1a3a5c"),
    spaceAfter=6,
    alignment=TA_CENTER,
)

subtitle_style = ParagraphStyle(
    "Subtitle",
    parent=styles["Normal"],
    fontSize=10,
    leading=14,
    textColor=colors.HexColor("#555555"),
    spaceAfter=12,
    alignment=TA_CENTER,
)

h1_style = ParagraphStyle(
    "H1",
    parent=styles["Heading1"],
    fontSize=13,
    leading=17,
    textColor=colors.HexColor("#1a3a5c"),
    spaceBefore=16,
    spaceAfter=4,
    borderPad=2,
)

h2_style = ParagraphStyle(
    "H2",
    parent=styles["Heading2"],
    fontSize=11,
    leading=15,
    textColor=colors.HexColor("#2c5f8a"),
    spaceBefore=10,
    spaceAfter=3,
)

body_style = ParagraphStyle(
    "Body",
    parent=styles["Normal"],
    fontSize=10,
    leading=15,
    textColor=colors.HexColor("#222222"),
    spaceAfter=6,
    alignment=TA_JUSTIFY,
)

bullet_style = ParagraphStyle(
    "Bullet",
    parent=styles["Normal"],
    fontSize=10,
    leading=14,
    textColor=colors.HexColor("#222222"),
    leftIndent=16,
    spaceAfter=3,
    bulletIndent=4,
)

ref_style = ParagraphStyle(
    "Ref",
    parent=styles["Normal"],
    fontSize=9,
    leading=13,
    textColor=colors.HexColor("#444444"),
    leftIndent=10,
    spaceAfter=3,
)

story = []

# Title
story.append(Spacer(1, 0.3*cm))
story.append(Paragraph("Sinonasal Undifferentiated Carcinoma", title_style))
story.append(Paragraph("A Comprehensive Essay", subtitle_style))
story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor("#1a3a5c"), spaceAfter=14))

# ─── INTRODUCTION ───────────────────────────────────────────────────────────
story.append(Paragraph("Introduction", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
story.append(Paragraph(
    "Sinonasal undifferentiated carcinoma (SNUC) is a rare, highly aggressive malignant epithelial "
    "neoplasm of the nasal cavity and paranasal sinuses. It was first recognised as a distinct "
    "clinicopathological entity by Mills and colleagues in 1987 and is defined by the absence of "
    "squamous, glandular, or neuroendocrine differentiation on light microscopy. Because of its "
    "rarity, most clinical data derive from retrospective series spanning decades and small "
    "institutional cohorts. Despite multimodal treatment advances, SNUC carries one of the worst "
    "prognoses among all sinonasal malignancies.",
    body_style
))

# ─── EPIDEMIOLOGY ────────────────────────────────────────────────────────────
story.append(Paragraph("Epidemiology and Aetiology", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
story.append(Paragraph(
    "SNUC is exceedingly rare, accounting for fewer than 5% of all sinonasal malignancies. "
    "It shows a male predominance (approximately 2:1) and most commonly presents in the fifth "
    "to sixth decade of life. Unlike sinonasal squamous cell carcinoma, there is no established "
    "causative link with occupational exposures (nickel, chromium, hardwood dust), tobacco, or "
    "EBV infection. The aetiology remains largely unknown.",
    body_style
))
story.append(Paragraph(
    "Recent genomic studies have substantially reshaped the classification of undifferentiated "
    "sinonasal tumours. Several molecularly distinct entities — previously grouped under the SNUC "
    "umbrella — have been delineated:",
    body_style
))
for item in [
    "<b>IDH2-mutant SNUC</b> — carries somatic IDH2 hotspot mutations and a distinctive histomorphology",
    "<b>SMARCA4-deficient sinonasal carcinoma</b> — loss of SWI/SNF chromatin remodelling complex subunit",
    "<b>NUT (nuclear protein in testis) midline carcinoma</b> — defined by NUT gene rearrangement; extremely aggressive",
    "<b>SMARCB1-deficient sinonasal carcinoma</b>",
]:
    story.append(Paragraph(f"• {item}", bullet_style))
story.append(Spacer(1, 4))
story.append(Paragraph(
    "This means that historical series may actually describe heterogeneous tumour populations, "
    "complicating the interpretation of outcomes data. Modern pathological re-review with "
    "molecular profiling is therefore essential.",
    body_style
))

# ─── PATHOLOGY ───────────────────────────────────────────────────────────────
story.append(Paragraph("Pathology", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))

story.append(Paragraph("Gross Features", h2_style))
story.append(Paragraph(
    "Tumours are bulky, fleshy masses that are locally destructive and frequently involve multiple "
    "sinonasal subsites simultaneously at presentation. The nasal cavity, ethmoid sinuses, and "
    "maxillary sinuses are the most common primary sites.",
    body_style
))

story.append(Paragraph("Histology", h2_style))
story.append(Paragraph(
    "SNUC is composed of <b>small round blue cells</b> arranged in nests, sheets, trabeculae, "
    "or ribbons with prominent necrosis and a high mitotic index. There is no squamous pearl "
    "formation, mucin production, or Homer Wright rosette formation. Pleomorphism is moderate "
    "to marked.",
    body_style
))

story.append(Paragraph("Immunohistochemistry (IHC)", h2_style))
story.append(Paragraph(
    "The IHC profile is critical for distinguishing SNUC from related small round cell tumours:",
    body_style
))

# IHC Table
ihc_data = [
    ["Marker", "SNUC", "ENB", "SNEC"],
    ["Cytokeratin (CK)", "Positive", "Negative", "Positive"],
    ["EMA", "Positive", "Focal", "Positive"],
    ["NSE", "Weak +", "Positive", "Positive (diffuse)"],
    ["Chromogranin", "Negative", "Strongly +", "Positive"],
    ["Synaptophysin", "Negative", "Strongly +", "Positive"],
    ["S100", "Negative", "Sustentacular +", "Variable"],
    ["p63/p40", "Negative", "Negative", "Negative"],
]

ihc_table = Table(ihc_data, colWidths=[4.5*cm, 3.5*cm, 3.5*cm, 4.5*cm])
ihc_table.setStyle(TableStyle([
    ("BACKGROUND", (0, 0), (-1, 0), colors.HexColor("#1a3a5c")),
    ("TEXTCOLOR", (0, 0), (-1, 0), colors.white),
    ("FONTNAME", (0, 0), (-1, 0), "Helvetica-Bold"),
    ("FONTSIZE", (0, 0), (-1, -1), 9),
    ("ALIGN", (0, 0), (-1, -1), "CENTER"),
    ("VALIGN", (0, 0), (-1, -1), "MIDDLE"),
    ("ROWBACKGROUNDS", (0, 1), (-1, -1), [colors.HexColor("#f0f4f8"), colors.white]),
    ("GRID", (0, 0), (-1, -1), 0.5, colors.HexColor("#aaaaaa")),
    ("TOPPADDING", (0, 0), (-1, -1), 5),
    ("BOTTOMPADDING", (0, 0), (-1, -1), 5),
]))
story.append(ihc_table)
story.append(Spacer(1, 4))
story.append(Paragraph(
    "<i>ENB = esthesioneuroblastoma; SNEC = sinonasal neuroendocrine carcinoma. "
    "Source: K.J. Lee's Essential Otolaryngology.</i>",
    ref_style
))

story.append(Paragraph("Differential Diagnosis", h2_style))
diffs = [
    "<b>Esthesioneuroblastoma (ENB)</b> — CK negative, S100-positive sustentacular cells, Homer Wright rosettes",
    "<b>Sinonasal neuroendocrine carcinoma (SNEC)</b> — CK positive but diffusely expresses neuroendocrine markers",
    "<b>NUT carcinoma</b> — requires FISH or IHC for NUT protein; extremely aggressive",
    "<b>Lymphoma</b> — CD45+, CK negative",
    "<b>Rhabdomyosarcoma</b> — desmin, myogenin positive",
    "<b>Mucosal melanoma</b> — HMB-45, Melan-A, S100 positive",
    "<b>Nasopharyngeal carcinoma (NPC)</b> — EBER in situ hybridisation positive",
]
for d in diffs:
    story.append(Paragraph(f"• {d}", bullet_style))
story.append(Spacer(1, 4))
story.append(Paragraph(
    "A 2024 review by Tandon &amp; Kakkar emphasises that histologic features overlap considerably, "
    "and that IHC, in situ hybridisation, and molecular testing are all necessary for a definitive "
    "diagnosis (Surg Pathol Clin, PMID 39489553).",
    body_style
))

# ─── CLINICAL FEATURES ───────────────────────────────────────────────────────
story.append(Paragraph("Clinical Features", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
story.append(Paragraph(
    "SNUC typically presents at an advanced stage — approximately 80% of patients have T4 disease "
    "at initial presentation. Presenting symptoms are non-specific and include:",
    body_style
))
clinical = [
    "<b>Unilateral nasal obstruction</b> and epistaxis (most common)",
    "<b>Facial pain</b> and swelling",
    "<b>Proptosis, diplopia, epiphora</b> — orbital involvement",
    "<b>Trismus</b> — pterygoid/infratemporal fossa involvement",
    "<b>Cranial nerve palsies</b> — skull base involvement (CN II, V, VI most common)",
    "<b>Headache</b> — intracranial extension",
]
for c in clinical:
    story.append(Paragraph(f"• {c}", bullet_style))
story.append(Spacer(1, 4))
story.append(Paragraph(
    "Symptom overlap with chronic rhinosinusitis frequently leads to diagnostic delay.",
    body_style
))

# ─── STAGING ─────────────────────────────────────────────────────────────────
story.append(Paragraph("Staging", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
story.append(Paragraph(
    "SNUC is staged using the AJCC/UICC TNM system for nasal cavity and paranasal sinus primaries:",
    body_style
))
staging = [
    ["T Stage", "Description"],
    ["T1", "Confined to one subsite, without bony erosion"],
    ["T2", "Extension to adjacent subsite or adjacent region"],
    ["T3", "Extension to medial orbital floor/wall, maxillary sinus, palate, or cribriform plate"],
    ["T4a", "Anterior skull base, orbital contents, pterygoid plates, frontal/sphenoid sinuses"],
    ["T4b", "Orbital apex, dura, brain, CN involvement (very advanced, unresectable)"],
]
staging_table = Table(staging, colWidths=[2.5*cm, 13.5*cm])
staging_table.setStyle(TableStyle([
    ("BACKGROUND", (0, 0), (-1, 0), colors.HexColor("#2c5f8a")),
    ("TEXTCOLOR", (0, 0), (-1, 0), colors.white),
    ("FONTNAME", (0, 0), (-1, 0), "Helvetica-Bold"),
    ("FONTSIZE", (0, 0), (-1, -1), 9),
    ("ALIGN", (0, 0), (0, -1), "CENTER"),
    ("VALIGN", (0, 0), (-1, -1), "MIDDLE"),
    ("ROWBACKGROUNDS", (0, 1), (-1, -1), [colors.HexColor("#f0f4f8"), colors.white]),
    ("GRID", (0, 0), (-1, -1), 0.5, colors.HexColor("#aaaaaa")),
    ("TOPPADDING", (0, 0), (-1, -1), 5),
    ("BOTTOMPADDING", (0, 0), (-1, -1), 5),
    ("FONTNAME", (0, 1), (0, -1), "Helvetica-Bold"),
]))
story.append(staging_table)
story.append(Spacer(1, 6))
story.append(Paragraph(
    "Regional (cervical) nodal involvement is present in 10–30% at diagnosis. Distant metastases "
    "(lungs, bone, liver) are common even after local control.",
    body_style
))

# ─── IMAGING ─────────────────────────────────────────────────────────────────
story.append(Paragraph("Imaging", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))

story.append(Paragraph("CT", h2_style))
story.append(Paragraph(
    "CT is essential for delineating bony destruction. Findings typically show an aggressive "
    "soft-tissue mass with extensive bone erosion across multiple sinuses and the skull base.",
    body_style
))

story.append(Paragraph("MRI", h2_style))
story.append(Paragraph(
    "MRI is superior for assessing soft-tissue extent — orbital, dural, and brain invasion. "
    "SNUC typically demonstrates intermediate T1 signal, intermediate-to-low T2 signal "
    "(reflecting high cellularity), avid heterogeneous contrast enhancement, and "
    "<b>restricted diffusion on DWI</b> (low apparent diffusion coefficient/ADC) owing to "
    "its hypercellular architecture.",
    body_style
))

story.append(Paragraph("PET-CT", h2_style))
story.append(Paragraph(
    "PET-CT is valuable for detecting occult nodal metastases (including retropharyngeal nodes), "
    "distant metastatic disease, and for assessing treatment response.",
    body_style
))

# ─── MANAGEMENT ──────────────────────────────────────────────────────────────
story.append(Paragraph("Management", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
story.append(Paragraph(
    "Given the rarity of SNUC, there are no prospective randomised trials. Management is based "
    "on retrospective series, institutional protocols, and meta-analyses, and must be conducted "
    "in a multidisciplinary setting.",
    body_style
))

story.append(Paragraph("Surgery", h2_style))
story.append(Paragraph(
    "Complete gross surgical resection confers the best local control. In a UCSF series, "
    "5-year local control was <b>74% for gross total resection vs. 24% for subtotal resection</b>, "
    "underscoring the critical importance of achieving negative margins "
    "(Cummings Otolaryngology Head and Neck Surgery).",
    body_style
))
story.append(Paragraph("Surgical approaches include:", body_style))
for item in [
    "<b>Craniofacial resection (CFR)</b> — historical gold standard; combined transfacial and frontal craniotomy for en-bloc resection with pericranial flap reconstruction. Mortality ~4.7%, morbidity 33–36%",
    "<b>Endoscopic endonasal approach (EEA)</b> — increasingly favoured; avoids facial incisions and craniotomy, provides excellent magnification. Suitable for select cases without significant lateral or orbital extension",
]:
    story.append(Paragraph(f"• {item}", bullet_style))

story.append(Paragraph("Radiation Therapy", h2_style))
story.append(Paragraph(
    "Radiation is an essential component of treatment. <b>IMRT</b> is the standard technique, "
    "enabling high-dose conformal delivery while sparing adjacent critical structures (optic "
    "apparatus, brainstem, temporal lobes). <b>Proton beam therapy</b> offers a dosimetric "
    "advantage in skull base lesions through the Bragg peak effect, reducing integral dose to "
    "surrounding tissues.",
    body_style
))

story.append(Paragraph("Chemotherapy", h2_style))
story.append(Paragraph(
    "SNUC is chemosensitive. Platinum-based regimens (cisplatin ± 5-fluorouracil; or cisplatin "
    "+ etoposide) are used in two settings:",
    body_style
))
for item in [
    "<b>Induction (neoadjuvant) chemotherapy</b> — followed by concurrent chemoradiation or surgery",
    "<b>Concurrent chemoradiation</b> — for unresectable disease or organ preservation strategy",
]:
    story.append(Paragraph(f"• {item}", bullet_style))
story.append(Spacer(1, 4))
story.append(Paragraph(
    "A landmark 2024 meta-analysis by Burggraf et al. (Head Neck, PMID 39162231) — analysing "
    "192 patients with individual patient data — demonstrated <b>5-year OS of 72.6% in patients "
    "receiving induction chemotherapy vs. 44.5% without induction chemotherapy</b>, concluding "
    "that induction chemotherapy should be considered in every patient diagnosed with SNUC.",
    body_style
))

story.append(Paragraph("Trimodality Therapy", h2_style))
story.append(Paragraph(
    "Multiple studies support trimodality therapy (induction chemotherapy + chemoradiation + "
    "surgery) as the most effective approach:",
    body_style
))
for item in [
    "Rischin et al.: 2-year OS of 64% with induction platinum/5-FU → concurrent platinum-based chemoRT",
    "Rosenthal et al. (MD Anderson, n=18): 5-year OS of 64.2% with combination therapy",
    "Mourad et al.: improved local control and freedom from distant metastasis with trimodality vs. single/dual modality",
    "Morand et al. meta-analysis (29 series, 390 patients): single-modality therapy associated with nearly 3-fold increased risk of death (HR 2.97 vs. dual; HR 2.80 vs. triple modality). Best outcomes with surgery + radiation",
]:
    story.append(Paragraph(f"• {item}", bullet_style))

story.append(Paragraph("Neck Management", h2_style))
story.append(Paragraph(
    "Elective neck treatment is warranted even in clinically N0 patients. The Morand meta-analysis "
    "found 27% of patients experienced regional failure at 2 years. Elective neck irradiation "
    "(approximately 50 Gy equivalent) is incorporated into radiotherapy planning as standard practice.",
    body_style
))

# ─── PROGNOSIS ───────────────────────────────────────────────────────────────
story.append(Paragraph("Prognosis", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
story.append(Paragraph(
    "SNUC carries a poor prognosis, particularly with single-modality therapy:",
    body_style
))
prog_data = [
    ["Series / Study", "5-year OS"],
    ["International collaborative study (n=14 undifferentiated)", "0%"],
    ["University of Michigan (single-institution)", "22%"],
    ["Modern multimodal treatment series", "44–65%"],
    ["Burggraf et al. 2024 meta-analysis (pooled, 13 studies)", "43.8%"],
    ["With induction chemotherapy (Burggraf 2024)", "72.6%"],
    ["Without induction chemotherapy (Burggraf 2024)", "44.5%"],
]
prog_table = Table(prog_data, colWidths=[11*cm, 5*cm])
prog_table.setStyle(TableStyle([
    ("BACKGROUND", (0, 0), (-1, 0), colors.HexColor("#1a3a5c")),
    ("TEXTCOLOR", (0, 0), (-1, 0), colors.white),
    ("FONTNAME", (0, 0), (-1, 0), "Helvetica-Bold"),
    ("FONTSIZE", (0, 0), (-1, -1), 9),
    ("ALIGN", (1, 0), (1, -1), "CENTER"),
    ("VALIGN", (0, 0), (-1, -1), "MIDDLE"),
    ("ROWBACKGROUNDS", (0, 1), (-1, -1), [colors.HexColor("#f0f4f8"), colors.white]),
    ("GRID", (0, 0), (-1, -1), 0.5, colors.HexColor("#aaaaaa")),
    ("TOPPADDING", (0, 0), (-1, -1), 5),
    ("BOTTOMPADDING", (0, 0), (-1, -1), 5),
]))
story.append(prog_table)
story.append(Spacer(1, 6))
story.append(Paragraph("Principal modes of treatment failure:", body_style))
for item in [
    "<b>Locoregional recurrence</b> — especially in incompletely resected or unresected disease",
    "<b>Distant metastases</b> — lungs, bone, liver; common even after local control",
]:
    story.append(Paragraph(f"• {item}", bullet_style))
story.append(Spacer(1, 4))
story.append(Paragraph(
    "Adverse prognostic factors include advanced T stage, skull base/dural invasion, nodal "
    "metastasis, incomplete resection, and absence of chemotherapy.",
    body_style
))

# ─── MOLECULAR ───────────────────────────────────────────────────────────────
story.append(Paragraph("Molecular Subtypes and Targeted Therapy", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
story.append(Paragraph(
    "The recognition of IDH2-mutant SNUC is clinically important: IDH2 mutations are potentially "
    "targetable with inhibitors (e.g., enasidenib). These tumours may carry a more favourable "
    "biology compared to IDH-wild-type SNUC. Molecular profiling of all newly diagnosed cases is "
    "increasingly recommended to:",
    body_style
))
for item in [
    "Identify actionable mutations (IDH2, FGFR, etc.)",
    "Correctly classify tumours within the spectrum of sinonasal undifferentiated/poorly differentiated carcinomas",
    "Stratify patients for clinical trial enrolment",
    "Guide targeted therapy, particularly for SMARCA4-deficient and NUT-rearranged tumours",
]:
    story.append(Paragraph(f"• {item}", bullet_style))

# ─── SUMMARY ─────────────────────────────────────────────────────────────────
story.append(Paragraph("Summary", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
summary_points = [
    "Rare, highly lethal sinonasal malignancy first described in 1987",
    "Presents at advanced stage (T4 in ~80%); high rates of distant metastasis",
    "Histology: small round blue cells, CK+, EMA+, neuroendocrine marker negative",
    "Mandatory exclusion of ENB, SNEC, NUT carcinoma, and other small round cell tumours via IHC and molecular testing",
    "Multimodal treatment is essential: induction chemotherapy improves 5-year OS to ~72.6% vs. 44.5% without (Burggraf 2024)",
    "5-year OS near zero with single modality; ~44–73% with modern multimodal approaches",
    "Elective neck treatment warranted due to 27% regional failure rate",
    "Emerging molecular classification (IDH2, SMARCA4, NUT) reshaping nosology and opening targeted therapy avenues",
]
for point in summary_points:
    story.append(Paragraph(f"• {point}", bullet_style))

# ─── REFERENCES ──────────────────────────────────────────────────────────────
story.append(Paragraph("Key References", h1_style))
story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor("#cccccc"), spaceAfter=6))
refs = [
    "Cummings Otolaryngology Head and Neck Surgery, 7th edition — Skull Base chapter (pp. 2277–2278)",
    "K.J. Lee's Essential Otolaryngology, 10th edition — Skull Base Malignancies (pp. 593, 599)",
    "Burggraf M et al. Contemporary treatment and outcome of sinonasal undifferentiated carcinoma: A meta-analysis. Head Neck. 2024 Nov. [PMID: 39162231]",
    "Tandon A, Kakkar A. Sinonasal Undifferentiated and Poorly Differentiated Carcinomas: An Update. Surg Pathol Clin. 2024 Dec. [PMID: 39489553]",
    "Morand GB et al. Meta-analysis of 29 case series encompassing 390 SNUC patients.",
    "Rischin D et al. Promising results with chemoradiation in SNUC. Head Neck. 2004;26:435–441.",
    "Rosenthal DI et al. MD Anderson Cancer Center — trimodality SNUC series.",
]
for i, r in enumerate(refs, 1):
    story.append(Paragraph(f"{i}. {r}", ref_style))

# Footer note
story.append(Spacer(1, 0.5*cm))
story.append(HRFlowable(width="100%", thickness=1, color=colors.HexColor("#1a3a5c"), spaceAfter=6))
story.append(Paragraph(
    "<i>Generated by Orris Medical Assistant · May 2026</i>",
    ParagraphStyle("Footer", parent=styles["Normal"], fontSize=8,
                   textColor=colors.HexColor("#888888"), alignment=TA_CENTER)
))

doc.build(story)
print(f"PDF generated: {OUTPUT}")
Running Command

python /home/daytona/workspace/snuc-essay/generate_pdf.py

Your PDF is ready:

SNUC Essay

PDF Document · PDF

The document includes all sections from the essay — introduction, epidemiology, pathology (with the IHC comparison table), clinical features, staging (with TNM table), imaging, management, prognosis (with outcomes table), molecular subtypes, summary, and references — formatted with a clean two-tone header style, section dividers, and proper A4 layout.

Explain in detail surgical management of nose and pns tumors , surgical technique used for different tnm stages of maxilla , ethmoid and nasal cavity

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive material. Let me compile the full detailed essay.

Surgical Management of Nose and Paranasal Sinus Tumours: Techniques by TNM Stage


I. Overview and Principles

The primary treatment goal for sinonasal malignancies is complete surgical resection with negative margins. This principle underpins all decisions, regardless of approach. Surgery is typically combined with postoperative radiotherapy (and increasingly chemotherapy), forming the cornerstone of curative treatment.
The type of procedure selected depends on:
  • Tumour location and subsite (maxillary sinus, nasal cavity, ethmoid, frontal, sphenoid)
  • T-stage — specifically, invasion of adjacent subsites and vital structures
  • Histology (SCC, adenocarcinoma, SNUC, olfactory neuroblastoma, etc.)
  • Surgeon experience and institutional capacity
A critical anatomical landmark is Ohngren's line — an imaginary plane from the medial canthus to the angle of the jaw. Infrastructural lesions (anterior/inferior to the line) present earlier and are more likely to be completely resected. Suprastructural lesions (posterior/superior) more frequently involve the orbit, skull base, infratemporal fossa, and carotid artery, conferring a markedly worse prognosis.

II. AJCC TNM Staging (8th Edition) — Maxillary Sinus

T StageCriteria
T1Tumour limited to maxillary sinus mucosa, no bony erosion or destruction
T2Tumour causing bone erosion/destruction including extension to hard palate and/or middle nasal meatus, except posterior wall of maxillary sinus and pterygoid plates
T3Tumour invades any of: posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses
T4aModerately advanced: invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses
T4bVery advanced: invades orbital apex, dura, brain, middle cranial fossa, cranial nerves other than V2, nasopharynx, or clivus

III. AJCC TNM Staging (8th Edition) — Nasal Cavity and Ethmoid Sinus

T StageCriteria
T1Tumour restricted to any one subsite, with or without bony invasion
T2Tumour invades two subsites in a single region or extends to an adjacent region within the nasoethmoid complex, with or without bony invasion
T3Tumour extends to medial orbital wall/floor, maxillary sinus, palate, or cribriform plate
T4aModerately advanced: invades anterior orbital contents, skin of nose or cheek, anterior cranial fossa (minimal extension), pterygoid plates, sphenoid or frontal sinuses
T4bVery advanced: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than V2, nasopharynx, or clivus

IV. Preoperative Assessment

Before any surgical intervention, the following are mandatory:
  1. Biopsy — Transnasal biopsy is the first step. Prior to biopsy, MRI must exclude an encephalocele or highly vascular tumour (e.g., juvenile nasopharyngeal angiofibroma). Biopsy should not violate surgical planes — avoid Caldwell-Luc approaches for biopsy as they may contaminate soft tissue planes in the cheek.
  2. CT scan — Defines bony architecture, extent of erosion, and lymph node metastases.
  3. MRI — Superior for soft tissue invasion, orbital, dural, and brain involvement; perineural invasion along V2/V3; medullary bone involvement.
  4. PET-CT — For detecting distant metastases and occult nodal disease (retropharyngeal nodes). Note: sinonasal inflammation can cause false-positive FDG uptake.
  5. Multidisciplinary tumour board review before treatment initiation.
  6. Dental evaluation and prosthodontic planning — Prefabricated obturators must be prepared before maxillectomy; gastrostomy tube consultation for nutritional support.

V. Surgical Approaches: Principles

Open vs. Endoscopic

FeatureOpenEndoscopic
ExposureSuperior; en bloc resectionHigh-definition magnified view; no craniofacial dissection
Best forAdvanced disease, lateral/orbital/skull base extensionMedial, superior, endoluminal disease without soft tissue extension
LimitationsCosmetic morbidity; facial incisions; retraction injuryNot suited for facial/orbital soft tissue extension, palatal involvement, dural involvement beyond mid-pupillary line
PrincipleStrict oncologic marginsStrict oncologic margins

VI. Surgical Techniques by Approach

A. Caldwell-Luc (Sublabial) Approach

Indications: Small, limited infrastructural malignancies — upper alveolar ridge, anterior nasal cavity, hard palate, anterolateral maxillary sinus.
Technique:
  • Incision through ipsilateral gingivobuccal mucosa, leaving an inferior cuff for closure
  • Can be extended bilaterally for a degloving approach
  • Provides access to the anterior maxillary wall
  • An obturator is prefabricated if entry into the maxillary sinus is anticipated
  • For limited alveolar ridge lesions, an alveolectomy is performed with a prefabricated denture

B. Lateral Rhinotomy

Indications: Lesions not involving the orbit or palate — nasal cavity, medial maxillary wall, ethmoid sinuses.
Technique:
  • Incision begins at the philtrum above the lip, across the nasal floor, around the lateral nasal ala, then along the nasal sidewall junction to the medial canthus
  • A modified variation hugs the lateral alar groove and travels up the medial sidewall to reduce alar distortion and ectropion
  • Extensions depending on disease extent:
    • Lynch extension (up to medial eyebrow): medial orbital wall, lacrimal apparatus
    • Subciliary extension (lateral along lower eyelid crease to zygoma): orbital floor access
    • Weber-Ferguson incision (incorporates an upper lip split): enhanced inferior access to palate for total maxillectomy

C. Medial Maxillectomy

Indications: Lesions involving the entire lateral nasal wall, not extending to: orbit, anterior cranial fossa, lateral maxilla, or alveolus. Typically T1–T2 nasal cavity/ethmoid tumours.
Resection includes: Middle and inferior turbinates, contents of ethmoid and maxillary sinuses, and the entire medial maxillary wall.
Technique (open):
  1. Extended lateral rhinotomy incision; upper cheek flap raised
  2. Anterior maxillary sinus wall burred out for exposure
  3. Medial wall periosteum incised and elevated off orbital rim and lamina papyracea
  4. Medial canthal ligament transected and tagged for reattachment
  5. Lacrimal sac and duct elevated; duct transected flush at the orbital rim
  6. Anterior and posterior ethmoid arteries identified and ligated
  7. Curved osteotome frees the medial maxillary wall parallel to the nasal floor
  8. Posterior attachment divided near the choanae with angled scissors
  9. Nasolacrimal duct stented at closure; medial canthal ligament resutured to nasal bone; meticulous two-layer closure

D. Infrastructural Maxillectomy

Indications: T2 maxillary sinus lesions — tumours of the hard palate, alveolar ridge, and inferior maxillary sinus not reaching the orbital floor.
Resection: Dentition + alveolar ridge + hard palate (builds on medial maxillectomy)
Approach: Weber-Ferguson incision or sublabial

VII. Subtotal and Total Maxillectomy

Subtotal Maxillectomy

Indications: T2–T3 maxillary tumours — involving the maxillary antrum extensively, hard palate, medial orbital floor/wall, pterygoid fossa, but orbital floor preserved (if possible).
Approach: Weber-Ferguson incision with subciliary extension.
Technique:
  1. Upper cheek flap raised; lower eyelid portion delicately elevated off orbicularis oculi
  2. Flap taken laterally to 1 cm beyond the lateral canthus
  3. Orbicularis oculi and orbit dissected off the inferior orbital rim in subperiosteal fashion; elevation carried back to the orbital apex
  4. Masseter muscle attachment to inferior zygoma divided
  5. Intraoral: mucosal incision between lateral incisor and canine → posteriorly down midline of hard palate → to the soft palate junction → laterally to the maxillary tubercle → out to the gingivobuccal sulcus behind the last molar; medial pterygoid muscle attachments cut to free the maxilla
  6. Nasal cavity entered at the piriform recess
  7. Osteotomies:
    • Premaxilla into nasal cavity (anterior)
    • Nasal process and medial orbital rim; anterior maxilla divided preserving bony orbital floor
    • Zygomatic arch divided; lateral maxillary wall divided
    • Freed from pterygoid plates through the hamulus using large curved osteotome
  8. Specimen removed en bloc
  9. Reconstruction: obturator (skin graft + Xeroform packing, prefabricated dental obturator wired to preserved dentition) or microvascular free flap

Total Maxillectomy

Indications: T3 maxillary tumours with involvement of the orbital floor; tumours of the infrastructure and suprastructure with orbital floor invasion.
Difference from subtotal: Includes the orbital floor in the resection specimen (see Fig. 94.8B in Cummings).
Technique: Same as subtotal maxillectomy with additional removal of the orbital floor. The orbital contents are retracted superiorly and the floor osteotomised and included with the specimen. The orbital periosteum (periorbita) must be assessed — if intact and not infiltrated, the globe can be preserved.
Reconstruction: Orbital floor must be reconstructed (titanium mesh, bone graft, or free flap) to prevent enophthalmos and diplopia.

VIII. Total Maxillectomy with Orbital Exenteration

Indications: T4a disease — invasion of anterior orbital contents (periorbita breached, orbital fat/muscles involved). The globe cannot be preserved once the periorbita is infiltrated.
Contraindications to globe preservation: Periorbita invasion, adherence of tumour to extraocular muscles, fat infiltration, decreased visual acuity preoperatively from tumour compression.
Technique:
  1. Weber-Ferguson incision with standard total maxillectomy steps, then:
  2. The eyelids are sewn together with a running suture
  3. Circumferential skin incision made around the orbital rim; periorbita incised at the rim and dissected free of orbital walls
  4. Optic nerve and ophthalmic vessels divided deep at the orbital apex with heavy scissors or a cutting stapler
  5. The entire orbital contents removed en bloc with the maxillary specimen
  6. The resulting defect is lined with a split-thickness skin graft or filled with a free flap (commonly rectus abdominis or anterolateral thigh)
  7. The eyelid skin is fashioned into a socket lining or a prosthetic eye fitted postoperatively

IX. Craniofacial Resection (CFR)

Indications: T3–T4a disease of the ethmoid sinus and nasal cavity with cribriform plate involvement or anterior skull base extension; olfactory neuroblastoma; SNUC with intracranial extension.
CFR is the historical gold standard for skull base malignancies. Overall 5-year survival for sinonasal cancer undergoing CFR is approximately 50%K.J. Lee's Essential Otolaryngology.
Mortality: ~4.7%; Morbidity: 33–36% (wound 20%, systemic 5%, orbital 1.5%). Risk increased with medical comorbidities, prior radiation, dural invasion, and brain invasion.
Technique:
  1. Transcranial (neurosurgical) component: Bicoronal scalp incision; frontal craniotomy; frontal lobe retracted
  2. The dura is inspected and, if involved, excised and reconstructed
  3. The cribriform plate and olfactory bulbs are resected under direct intracranial vision
  4. The anterior skull base is osteotomised
  5. Transfacial (rhinological) component: Lateral rhinotomy, midfacial degloving, or Weber-Ferguson incision depending on tumour extent
  6. The sinonasal portion of the tumour is mobilised from below
  7. The specimen is delivered en bloc — nasal cavity, ethmoid complex, cribriform plate, and adherent dura if involved
  8. Reconstruction: Pericranial flap (most commonly) turned down to reconstruct the skull base and dural defect; supported from below with Xeroform packing in the nasal cavity; scalp closed primarily
Variants of extent (Fig. 94.8C and D in Cummings):
  • Limited CFR: ethmoid complex + cribriform plate
  • Extended CFR: adds orbital exenteration and/or additional skull base
  • Combined with maxillectomy for maxilloethmoid tumours

X. Endoscopic Approaches

Endoscopic Partial or Medial Maxillectomy

Indications: T1–T2 nasal cavity and ethmoid tumours without orbital, palatal, anterolateral frontal sinus, or facial soft tissue extension; inverted papilloma with focal malignant transformation; select adenocarcinomas.
Absolute contraindications to endoscopic approach:
  • Facial or orbital soft tissue extension
  • Significant palatal involvement
  • Anterolateral frontal sinus involvement
  • Dural involvement beyond the mid-pupillary line
  • Tumours requiring en bloc resection for margin control (certain histologies)
Advantages: No facial incisions; no craniotomy; no brain retraction; excellent magnification; reduced blood loss; shorter hospitalisation; ability to identify tumour origin by gradual debulking.
Technique:
  1. Nasoendoscopic exposure with 0° and 45° telescopes
  2. Posterior two-thirds of nasal septum may be removed for bilateral access (intersinus septectomy)
  3. Wide sphenoidotomy with intersinus septectomy for posterior exposure
  4. Sequential resection: identification of tumour origin → gradual debulking → progressive exposure of surgical margins
  5. For endoscopic medial maxillectomy: inferior turbinate removed, medial wall of maxillary sinus resected under direct vision; uncinectomy and maxillary antrostomy to achieve wide exposure
  6. Frozen section margin assessment during resection
  7. Skull base exposure for cribriform plate involvement via endoscopic craniofacial approach (without craniotomy for select T3 ethmoid lesions)

Endoscopic Endonasal Approach (EEA) for Skull Base

Indications: Select T3–T4a ethmoid/nasal cavity lesions with cribriform plate involvement, but without significant dural or frontal lobe involvement. Increasingly replacing CFR at experienced centres.
Advantages over CFR: No facial incisions; no frontal craniotomy; no brain retraction; equivalent oncologic outcomes reported in select series.
Key steps:
  1. Bilateral wide sphenoidotomy and intersinus septectomy
  2. Posterior nasal septum resected
  3. Complete ethmoidectomy
  4. Skull base exposed; anterior and posterior ethmoid arteries ligated
  5. Cribriform plate and olfactory bulbs resected under endoscopic vision
  6. Dural entry if involved; reconstruction with nasoseptal (Hadad-Bassagastellys) flap or pericranial flap via combined approach

XI. Stage-Specific Surgical Decision Framework

Maxillary Sinus

StageSurgical Procedure
T1Endoscopic medial maxillectomy (if medial wall); or Caldwell-Luc/sublabial for small anteroinferior lesions
T2Open medial maxillectomy via lateral rhinotomy; or infrastructural maxillectomy (alveolus/hard palate involvement)
T3Subtotal maxillectomy (Weber-Ferguson ± subciliary) preserving orbital floor if possible; or total maxillectomy if orbital floor is involved. Consider CFR if ethmoid/cribriform involved
T4aTotal maxillectomy + orbital exenteration for anterior orbital content invasion; ± craniofacial resection for skull base/anterior cranial fossa extension
T4bGenerally considered unresectable (orbital apex, dura with brain invasion, clivus, carotid involvement); primary chemoradiation or induction chemotherapy → reassess resectability

Nasal Cavity

StageSurgical Procedure
T1Endoscopic resection (partial endoscopic ethmoidectomy or nasal resection); lateral rhinotomy for anterior lesions
T2Open medial maxillectomy or extended endoscopic resection depending on subsite involvement
T3Medial maxillectomy + orbital floor/medial wall resection; or combined endoscopic-open approach for cribriform involvement
T4aCraniofacial resection ± orbital exenteration
T4bUnresectable; chemoradiation ± palliative surgery

Ethmoid Sinus

StageSurgical Procedure
T1Endoscopic total ethmoidectomy
T2Extended endoscopic ethmoidectomy ± medial maxillectomy
T3CFR (limited: ethmoid + cribriform plate) or endoscopic endonasal skull base resection at experienced centres; medial orbital wall resection if orbital invasion present
T4aCFR with orbital exenteration for anterior orbital contents involvement; extended endoscopic approach at expert centres
T4bUnresectable; chemoradiation primary

XII. Neck Management

  • Regional lymph node metastasis is uncommon at presentation (10–30%) but cervical failure contributes significantly to poor outcomes.
  • Elective neck dissection or irradiation is indicated for:
    • High-risk histologies (SCC, undifferentiated carcinoma)
    • T3–T4 primary tumours
    • Ipsilateral levels I–III are most commonly at risk
  • Therapeutic neck dissection for clinically positive nodes (selective or comprehensive depending on burden)

XIII. Reconstruction

Brown-Shaw Classification (Maxillectomy Defects)

Vertical (numbered I–VI): I = no oronasal fistula → IV = orbital exenteration → V = orbitomaxillary → VI = nasomaxillary
Horizontal (lettered A–D): A = palate only → D = >half maxillectomy

Reconstruction Options by Defect

Defect ClassReconstruction
I–IIb (≤half lateral alveolus and palate)Obturator OR radial forearm fasciocutaneous free flap
III (orbital support needed)Fibula free flap (bone + soft tissue) or scapular free flap
IV (with orbital exenteration)Rectus abdominis or anterolateral thigh (ALT) free flap; prosthetic eye
Skull basePericranial flap (CFR) or nasoseptal (Hadad) flap (endoscopic)
Microvascular free flap reconstruction has become standard for complex maxillectomy defects: it better restores facial contour, supports the orbital floor, accepts dental implants, and withstands postoperative radiation effects. Speech intelligibility and swallowing outcomes are generally superior to obturation for defects involving more than 50% of the palate.

XIV. Special Considerations

Orbital Preservation

The key decision in T3–T4 disease is whether to preserve the orbit. Indications for exenteration:
  • Periorbita breached with tumour infiltration of orbital fat
  • Extraocular muscle or optic nerve involvement
  • Decreased preoperative visual acuity
If the periorbita (orbital periosteum) is intact despite bony destruction of the orbital walls, the globe is typically preserved and postoperative radiation covers residual microscopic disease.

Perineural Invasion (PNI)

The most commonly affected nerves are V2 (maxillary), hypoglossal, V3, and facial nerve. PNI mandates wider resection along the nerve and tracking back to the Gasserian ganglion when V2/V3 are involved. MRI findings (widened neural foramina, enhancement, loss of fat planes) guide resection extent.

Unresectability Criteria

A tumour is generally considered unresectable if it involves:
  • Bilateral orbital apex involvement (bilateral blindness)
  • Brain parenchyma with involvement beyond the dura in non-eloquent cortex
  • Carotid artery encasement
  • Clivus or nasopharyngeal prevertebral muscles (implies prevertebral fascia fixation)
  • Bilateral cavernous sinus involvement

Summary

The surgical management of sinonasal malignancies is guided principally by anatomical extent (T stage), with the spectrum ranging from limited endoscopic resection for T1 disease to craniofacial resection with orbital exenteration for advanced T4a disease. T4b disease is generally unresectable and managed primarily with chemoradiation. The preferred overall approach for resectable sinonasal cancer remains complete surgical resection followed by postoperative radiotherapy, with chemotherapy added for high-risk histologies and advanced stages. At experienced centres, endoscopic endonasal approaches increasingly replace open CFR for select T3 ethmoid and nasal cavity tumours, offering equivalent oncological results with substantially reduced morbidity.

Sources: Cummings Otolaryngology Head and Neck Surgery, 7th ed. (Chapter 94, pp. 1735–1760); K.J. Lee's Essential Otolaryngology, 10th ed. (pp. 593–600)

Create pdf

Running Command

mkdir -p /home/daytona/workspace/sinonasal-surgery

Writing File

~/sinonasal-surgery/generate_pdf.py

from reportlab.lib.pagesizes import A4
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.units import cm
from reportlab.lib import colors
from reportlab.platypus import (
    SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle,
    HRFlowable, KeepTogether, PageBreak
)
from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY

OUTPUT = "/home/daytona/workspace/sinonasal-surgery/Sinonasal_Surgery_TNM.pdf"

doc = SimpleDocTemplate(
    OUTPUT,
    pagesize=A4,
    leftMargin=2.2*cm,
    rightMargin=2.2*cm,
    topMargin=2.5*cm,
    bottomMargin=2.5*cm,
    title="Surgical Management of Nose and PNS Tumours",
    author="Orris Medical",
)

styles = getSampleStyleSheet()

NAVY   = colors.HexColor("#1a3a5c")
BLUE   = colors.HexColor("#2c5f8a")
LTBLUE = colors.HexColor("#dce8f5")
GRAY   = colors.HexColor("#f4f6f9")
DKGRAY = colors.HexColor("#333333")
MID    = colors.HexColor("#555555")
RULE   = colors.HexColor("#c0cfe0")

title_style = ParagraphStyle("T", parent=styles["Title"],
    fontSize=19, leading=25, textColor=NAVY, alignment=TA_CENTER, spaceAfter=4)

subtitle_style = ParagraphStyle("Sub", parent=styles["Normal"],
    fontSize=10, leading=14, textColor=MID, alignment=TA_CENTER, spaceAfter=14)

h1 = ParagraphStyle("H1", parent=styles["Heading1"],
    fontSize=13, leading=17, textColor=NAVY,
    spaceBefore=16, spaceAfter=4, fontName="Helvetica-Bold")

h2 = ParagraphStyle("H2", parent=styles["Heading2"],
    fontSize=11, leading=15, textColor=BLUE,
    spaceBefore=10, spaceAfter=3, fontName="Helvetica-Bold")

h3 = ParagraphStyle("H3", parent=styles["Heading3"],
    fontSize=10, leading=14, textColor=BLUE,
    spaceBefore=6, spaceAfter=2, fontName="Helvetica-Bold")

body = ParagraphStyle("Body", parent=styles["Normal"],
    fontSize=9.5, leading=14.5, textColor=DKGRAY,
    spaceAfter=5, alignment=TA_JUSTIFY)

bul = ParagraphStyle("Bul", parent=styles["Normal"],
    fontSize=9.5, leading=14, textColor=DKGRAY,
    leftIndent=14, spaceAfter=3, bulletIndent=4)

subbul = ParagraphStyle("SubBul", parent=styles["Normal"],
    fontSize=9, leading=13, textColor=DKGRAY,
    leftIndent=26, spaceAfter=2, bulletIndent=14)

note = ParagraphStyle("Note", parent=styles["Normal"],
    fontSize=8.5, leading=12, textColor=MID,
    leftIndent=8, spaceAfter=3, fontName="Helvetica-Oblique")

ref_style = ParagraphStyle("Ref", parent=styles["Normal"],
    fontSize=8.5, leading=12, textColor=MID, leftIndent=10, spaceAfter=3)

footer_style = ParagraphStyle("Footer", parent=styles["Normal"],
    fontSize=8, textColor=colors.HexColor("#999999"), alignment=TA_CENTER)

def rule(sp_before=0, sp_after=6):
    return HRFlowable(width="100%", thickness=0.5, color=RULE,
                      spaceBefore=sp_before, spaceAfter=sp_after)

def h1rule(sp_after=6):
    return HRFlowable(width="100%", thickness=1.5, color=NAVY, spaceAfter=sp_after)

def bullets(items, style=bul, marker="•"):
    els = []
    for item in items:
        els.append(Paragraph(f"{marker}  {item}", style))
    return els

def table(data, col_widths, header_color=NAVY, stripe=True):
    t = Table(data, colWidths=col_widths)
    style_cmds = [
        ("BACKGROUND", (0,0), (-1,0), header_color),
        ("TEXTCOLOR",  (0,0), (-1,0), colors.white),
        ("FONTNAME",   (0,0), (-1,0), "Helvetica-Bold"),
        ("FONTSIZE",   (0,0), (-1,-1), 8.5),
        ("ALIGN",      (0,0), (-1,-1), "LEFT"),
        ("VALIGN",     (0,0), (-1,-1), "MIDDLE"),
        ("GRID",       (0,0), (-1,-1), 0.4, colors.HexColor("#bbbbbb")),
        ("TOPPADDING", (0,0), (-1,-1), 4),
        ("BOTTOMPADDING",(0,0),(-1,-1),4),
        ("LEFTPADDING",(0,0),(-1,-1),5),
    ]
    if stripe:
        for i in range(1, len(data)):
            bg = GRAY if i % 2 == 1 else colors.white
            style_cmds.append(("BACKGROUND", (0,i), (-1,i), bg))
    t.setStyle(TableStyle(style_cmds))
    return t

# ── Build story ──────────────────────────────────────────────────────────────
story = []

# Title block
story.append(Spacer(1, 0.2*cm))
story.append(Paragraph("Surgical Management of Nose and Paranasal Sinus Tumours", title_style))
story.append(Paragraph("Surgical Techniques by TNM Stage — Maxilla, Ethmoid &amp; Nasal Cavity", subtitle_style))
story.append(HRFlowable(width="100%", thickness=2.5, color=NAVY, spaceAfter=14))

# ── I. OVERVIEW ──────────────────────────────────────────────────────────────
story.append(KeepTogether([
    Paragraph("I. Overview and Principles", h1), h1rule(),
    Paragraph(
        "The primary treatment goal for sinonasal malignancies is <b>complete surgical "
        "resection with negative margins</b>. Surgery is typically combined with postoperative "
        "radiotherapy (and increasingly chemotherapy), forming the cornerstone of curative treatment. "
        "The type of procedure is governed by tumour location, T-stage, histology, and surgeon experience.",
        body),
    Paragraph("Key determinants of surgical approach:", body),
]))
story += bullets([
    "Tumour <b>location and subsite</b> (maxillary sinus, nasal cavity, ethmoid, frontal, sphenoid)",
    "<b>T-stage</b> — specifically, invasion of adjacent subsites and vital structures",
    "<b>Histology</b> (SCC, adenocarcinoma, SNUC, olfactory neuroblastoma, etc.)",
    "<b>Surgeon experience</b> and institutional capacity",
])
story.append(Spacer(1,4))
story.append(KeepTogether([
    Paragraph("Ohngren's Line", h3),
    Paragraph(
        "An imaginary plane from the <b>medial canthus to the angle of the jaw</b>. "
        "<b>Infrastructural lesions</b> (anterior/inferior) present earlier and are more likely "
        "to be completely resected. <b>Suprastructural lesions</b> (posterior/superior) more "
        "frequently involve the orbit, skull base, and carotid artery, conferring a markedly "
        "worse prognosis.", body),
]))

# ── II. TNM — MAXILLARY SINUS ────────────────────────────────────────────────
story.append(Paragraph("II. AJCC TNM Staging (8th Ed.) — Maxillary Sinus", h1))
story.append(h1rule())
mx_data = [
    ["T Stage", "Criteria"],
    ["T1", "Tumour limited to maxillary sinus mucosa; no bony erosion or destruction"],
    ["T2", "Bone erosion/destruction including hard palate and/or middle nasal meatus; excludes posterior wall and pterygoid plates"],
    ["T3", "Invades posterior wall of maxillary sinus, subcutaneous tissues, floor/medial wall of orbit, pterygoid fossa, ethmoid sinuses"],
    ["T4a", "Moderately advanced: anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid/frontal sinuses"],
    ["T4b", "Very advanced: orbital apex, dura, brain, middle cranial fossa, CN other than V2, nasopharynx, clivus"],
]
story.append(table(mx_data, [2*cm, 13.6*cm]))

# ── III. TNM — NASAL CAVITY & ETHMOID ────────────────────────────────────────
story.append(Paragraph("III. AJCC TNM Staging (8th Ed.) — Nasal Cavity &amp; Ethmoid Sinus", h1))
story.append(h1rule())
nc_data = [
    ["T Stage", "Criteria"],
    ["T1", "Restricted to any one subsite, with or without bony invasion"],
    ["T2", "Invades two subsites in a single region or extends to adjacent region within nasoethmoid complex, ± bony invasion"],
    ["T3", "Extends to medial orbital wall/floor, maxillary sinus, palate, or cribriform plate"],
    ["T4a", "Moderately advanced: anterior orbital contents, skin of nose/cheek, anterior cranial fossa (minimal), pterygoid plates, sphenoid/frontal sinuses"],
    ["T4b", "Very advanced: orbital apex, dura, brain, middle cranial fossa, CN other than V2, nasopharynx, clivus"],
]
story.append(table(nc_data, [2*cm, 13.6*cm]))

# ── IV. PREOPERATIVE ─────────────────────────────────────────────────────────
story.append(Paragraph("IV. Preoperative Assessment", h1))
story.append(h1rule())
pre_items = [
    "<b>Biopsy</b> — Transnasal biopsy is first-line. MRI must exclude encephalocele or vascular tumour beforehand. Avoid Caldwell-Luc biopsy — may contaminate cheek soft tissue planes",
    "<b>CT scan</b> — Defines bony architecture, extent of erosion, lymph node metastases",
    "<b>MRI</b> — Superior for soft tissue invasion, orbital/dural/brain involvement, perineural invasion along V2/V3, medullary bone",
    "<b>PET-CT</b> — Detects distant metastases and occult nodal disease; sinonasal inflammation causes false-positive FDG uptake",
    "<b>MDT tumour board</b> — Mandatory before treatment initiation",
    "<b>Dental evaluation &amp; prosthodontic planning</b> — Prefabricated obturators prepared pre-operatively",
    "<b>Nutritional assessment</b> — Gastrostomy tube consultation for anticipated prolonged dysphagia",
]
story += bullets(pre_items)

# ── V. OPEN vs ENDOSCOPIC ────────────────────────────────────────────────────
story.append(Paragraph("V. Open vs. Endoscopic Approaches", h1))
story.append(h1rule())
cmp_data = [
    ["Feature", "Open", "Endoscopic"],
    ["Exposure", "Superior; en bloc resection", "High-definition magnified view"],
    ["Facial incisions", "Required", "None"],
    ["Brain retraction", "May be required (CFR)", "None"],
    ["Best for", "Advanced; lateral/orbital/skull base extension", "Medial, superior, endoluminal disease"],
    ["Limitations", "Cosmetic morbidity; potential retraction injury",
     "Not for facial/orbital soft tissue, palatal involvement,\ndural extension beyond mid-pupillary line"],
    ["Oncologic principle", "Strict negative margins", "Strict negative margins"],
]
story.append(table(cmp_data, [3.5*cm, 6.5*cm, 5.6*cm], header_color=BLUE))

# ── VI. SURGICAL TECHNIQUES ──────────────────────────────────────────────────
story.append(Paragraph("VI. Surgical Techniques in Detail", h1))
story.append(h1rule())

# A. Caldwell-Luc
story.append(KeepTogether([
    Paragraph("A. Caldwell-Luc (Sublabial) Approach", h2),
    rule(),
    Paragraph("<b>Indications:</b> Small, limited infrastructural malignancies — upper alveolar ridge, anterior nasal cavity, hard palate, anterolateral maxillary sinus.", body),
    Paragraph("<b>Technique:</b>", body),
]))
story += bullets([
    "Incision through ipsilateral gingivobuccal mucosa, leaving an inferior cuff for closure",
    "Can be extended bilaterally for a degloving approach",
    "Obturator prefabricated if maxillary sinus entry is anticipated",
    "For limited alveolar ridge lesions: alveolectomy with prefabricated denture",
])

# B. Lateral Rhinotomy
story.append(KeepTogether([
    Paragraph("B. Lateral Rhinotomy", h2),
    rule(),
    Paragraph("<b>Indications:</b> Lesions not involving the orbit or palate — nasal cavity, medial maxillary wall, ethmoid sinuses.", body),
    Paragraph("<b>Technique:</b>", body),
]))
story += bullets([
    "Incision from philtrum → nasal floor → lateral nasal ala → nasal sidewall junction → medial canthus",
    "Modified variation hugs lateral alar groove to reduce ectropion and alar distortion",
])
story.append(Paragraph("<b>Extensions:</b>", body))
ext_data = [
    ["Extension", "Added Access"],
    ["Lynch (up to medial eyebrow)", "Medial orbital wall, lacrimal apparatus"],
    ["Subciliary (lower eyelid crease → zygoma)", "Orbital floor"],
    ["Weber-Ferguson (+ upper lip split)", "Hard palate, infraorbital access for total maxillectomy"],
]
story.append(table(ext_data, [7*cm, 8.6*cm], header_color=BLUE))

# C. Medial Maxillectomy
story.append(KeepTogether([
    Paragraph("C. Medial Maxillectomy", h2),
    rule(),
    Paragraph(
        "<b>Indications:</b> Lesions involving entire lateral nasal wall, NOT extending to orbit, "
        "anterior cranial fossa, lateral maxilla, or alveolus. Typically T1–T2 nasal cavity/ethmoid.", body),
    Paragraph("<b>Resection:</b> Middle and inferior turbinates + ethmoid contents + maxillary sinus contents + entire medial maxillary wall.", body),
    Paragraph("<b>Technique (open):</b>", body),
]))
story += bullets([
    "Extended lateral rhinotomy; upper cheek flap raised",
    "Anterior maxillary sinus wall burred out for exposure",
    "Medial wall periosteum incised; elevated off orbital rim and lamina papyracea",
    "Medial canthal ligament transected and tagged for reattachment",
    "Lacrimal sac and duct elevated; duct transected flush at orbital rim",
    "Anterior and posterior ethmoid arteries ligated",
    "Curved osteotome frees medial maxillary wall parallel to nasal floor",
    "Posterior attachments divided near choanae with angled scissors",
    "Closure: nasolacrimal duct stented; medial canthal ligament resutured to nasal bone; two-layer closure",
])

# D. Infrastructural Maxillectomy
story.append(KeepTogether([
    Paragraph("D. Infrastructural Maxillectomy", h2),
    rule(),
    Paragraph(
        "<b>Indications:</b> T2 maxillary tumours — hard palate, alveolar ridge, inferior "
        "maxillary sinus without orbital floor involvement.", body),
    Paragraph("<b>Resection:</b> Dentition + alveolar ridge + hard palate (builds on medial maxillectomy).", body),
    Paragraph("<b>Approach:</b> Weber-Ferguson incision or sublabial.", body),
]))

# VII. SUBTOTAL AND TOTAL MAXILLECTOMY
story.append(PageBreak())
story.append(Paragraph("VII. Subtotal and Total Maxillectomy", h1))
story.append(h1rule())

story.append(Paragraph("A. Subtotal Maxillectomy", h2))
story.append(rule())
story.append(Paragraph(
    "<b>Indications:</b> T2–T3 maxillary tumours — extensive antral disease, hard palate, "
    "medial orbital floor/wall, pterygoid fossa; <b>orbital floor preserved</b> if possible.",
    body))
story.append(Paragraph("<b>Approach:</b> Weber-Ferguson incision with subciliary extension.", body))
story.append(Paragraph("<b>Technique:</b>", body))
story += bullets([
    "Upper cheek flap raised; lower eyelid delicately elevated off orbicularis oculi",
    "Flap taken 1 cm beyond lateral canthus",
    "Orbit dissected off inferior orbital rim in subperiosteal fashion; elevated to orbital apex",
    "Masseter attachment to inferior zygoma divided",
    "<b>Intraoral:</b> mucosal incision lateral incisor–canine → midline hard palate → soft palate junction → maxillary tubercle → gingivobuccal sulcus; medial pterygoid cut",
    "Nasal cavity entered at piriform recess",
    "<b>Osteotomies:</b> premaxilla into nasal cavity; nasal process + medial orbital rim; anterior maxilla preserving orbital floor; zygomatic arch; lateral maxillary wall; pterygoid plates via hamulus (large curved osteotome)",
    "Specimen removed en bloc",
    "<b>Reconstruction:</b> obturator (skin graft + Xeroform, prefabricated dental obturator) OR microvascular free flap",
])
story.append(Spacer(1,8))

story.append(Paragraph("B. Total Maxillectomy", h2))
story.append(rule())
story.append(Paragraph(
    "<b>Indications:</b> T3 maxillary tumours with orbital floor invasion (infrastructure + suprastructure).",
    body))
story += bullets([
    "Same steps as subtotal maxillectomy with <b>additional resection of the orbital floor</b>",
    "Orbital contents retracted superiorly; floor osteotomised and included with specimen",
    "Periorbita (orbital periosteum) assessed — if intact and uninvaded, globe preserved",
    "<b>Reconstruction:</b> titanium mesh, bone graft, or free flap to reconstruct orbital floor and prevent enophthalmos/diplopia",
])
story.append(Spacer(1,8))

# VIII. ORBITAL EXENTERATION
story.append(Paragraph("VIII. Total Maxillectomy with Orbital Exenteration", h1))
story.append(h1rule())
story.append(Paragraph(
    "<b>Indications:</b> T4a disease — periorbita breached with tumour infiltration of orbital fat, "
    "extraocular muscles, or optic nerve. Globe cannot be preserved once periorbita is infiltrated.",
    body))
story.append(Paragraph("<b>Contraindications to globe preservation:</b>", body))
story += bullets([
    "Periorbita invasion; adherence to extraocular muscles",
    "Orbital fat infiltration",
    "Decreased preoperative visual acuity due to tumour compression",
])
story.append(Paragraph("<b>Technique (after standard total maxillectomy steps):</b>", body))
story += bullets([
    "Eyelids sewn together with running suture",
    "Circumferential skin incision around orbital rim; periorbita incised at rim",
    "Periorbita dissected free of all orbital walls",
    "Optic nerve and ophthalmic vessels divided deep at orbital apex (heavy scissors or cutting stapler)",
    "Entire orbital contents removed en bloc with maxillary specimen",
    "Defect lined with split-thickness skin graft or filled with free flap (rectus abdominis or ALT)",
    "Eyelid skin fashioned into socket lining; prosthetic eye fitted postoperatively",
])

# IX. CFR
story.append(Paragraph("IX. Craniofacial Resection (CFR)", h1))
story.append(h1rule())
story.append(Paragraph(
    "<b>Indications:</b> T3–T4a ethmoid and nasal cavity disease with cribriform plate or anterior "
    "skull base involvement; olfactory neuroblastoma; SNUC with intracranial extension. "
    "CFR is the <b>historical gold standard</b> for skull base malignancies — overall 5-year survival ~50%.",
    body))

cfr_stats = [
    ["Outcome", "Value"],
    ["Operative mortality", "~4.7%"],
    ["Overall morbidity", "33–36%"],
    ["Wound complications", "~20%"],
    ["Systemic complications", "~5%"],
    ["Orbital complications", "~1.5%"],
    ["Overall 5-year survival (all sinonasal CFR)", "~50%"],
]
story.append(table(cfr_stats, [7*cm, 8.6*cm], header_color=BLUE))
story.append(Spacer(1,6))
story.append(Paragraph("<b>Technique:</b>", body))
story += bullets([
    "<b>Transcranial (neurosurgical):</b> Bicoronal scalp incision → frontal craniotomy → frontal lobe retraction → inspect dura (resect if involved) → cribriform plate and olfactory bulbs resected under direct intracranial vision → anterior skull base osteotomised",
    "<b>Transfacial (rhinological):</b> Lateral rhinotomy / midfacial degloving / Weber-Ferguson depending on extent → sinonasal tumour mobilised from below",
    "Specimen delivered <b>en bloc</b>: nasal cavity + ethmoid complex + cribriform plate ± adherent dura",
    "<b>Reconstruction:</b> Pericranial flap turned down to reconstruct skull base and dural defect; supported from below with Xeroform packing; scalp closed primarily",
])
story.append(Paragraph("<b>Variants by extent:</b>", body))
story += bullets([
    "Limited CFR: ethmoid complex + cribriform plate",
    "Extended CFR: adds orbital exenteration and/or additional skull base",
    "Combined CFR + maxillectomy for maxilloethmoid tumours",
])

# X. ENDOSCOPIC
story.append(PageBreak())
story.append(Paragraph("X. Endoscopic Approaches", h1))
story.append(h1rule())

story.append(Paragraph("A. Endoscopic Medial Maxillectomy / Partial Resection", h2))
story.append(rule())
story.append(Paragraph(
    "<b>Indications:</b> T1–T2 nasal cavity and ethmoid tumours without orbital, palatal, "
    "anterolateral frontal sinus, or facial soft tissue extension; inverted papilloma with "
    "focal malignant transformation; select low-grade adenocarcinomas.",
    body))
story.append(Paragraph("<b>Absolute contraindications:</b>", body))
story += bullets([
    "Facial or orbital soft tissue extension",
    "Significant palatal involvement",
    "Anterolateral frontal sinus involvement",
    "Dural extension beyond the mid-pupillary line",
    "Tumours requiring strict en bloc margins",
], style=bul, marker="✕")
story.append(Paragraph("<b>Technique:</b>", body))
story += bullets([
    "0° and 45° telescopes; posterior 2/3 of nasal septum removed for bilateral access",
    "Wide sphenoidotomy with intersinus septectomy for posterior exposure",
    "Sequential resection: tumour origin identified → gradual debulking → progressive margin exposure",
    "Inferior turbinate removed; medial maxillary wall resected under direct vision via uncinectomy + wide antrostomy",
    "Frozen section margin assessment intraoperatively",
])
story.append(Spacer(1,8))

story.append(Paragraph("B. Endoscopic Endonasal Approach (EEA) for Skull Base", h2))
story.append(rule())
story.append(Paragraph(
    "<b>Indications:</b> Select T3–T4a ethmoid/nasal cavity lesions with cribriform plate "
    "involvement but without significant frontal lobe involvement. Increasingly replacing CFR at "
    "expert centres with equivalent oncological outcomes and reduced morbidity.",
    body))
story += bullets([
    "Bilateral wide sphenoidotomy; intersinus septectomy; posterior nasal septum resected",
    "Complete ethmoidectomy; skull base exposed",
    "Anterior and posterior ethmoid arteries ligated",
    "Cribriform plate and olfactory bulbs resected under endoscopic vision",
    "Dural entry if involved → reconstruction with <b>nasoseptal (Hadad-Bassagastellys) flap</b>",
])

# XI. STAGE-SPECIFIC TABLES
story.append(Paragraph("XI. Stage-Specific Surgical Decision Framework", h1))
story.append(h1rule())

story.append(Paragraph("A. Maxillary Sinus", h2))
story.append(rule())
max_surg = [
    ["Stage", "Surgical Procedure"],
    ["T1", "Endoscopic medial maxillectomy (medial wall lesions); Caldwell-Luc/sublabial for small anteroinferior lesions"],
    ["T2", "Open medial maxillectomy (lateral rhinotomy); or infrastructural maxillectomy if alveolus/hard palate involved"],
    ["T3", "Subtotal maxillectomy (Weber-Ferguson ± subciliary) preserving orbital floor if possible; Total maxillectomy if orbital floor invaded; ± CFR if cribriform involved"],
    ["T4a", "Total maxillectomy + orbital exenteration for anterior orbital invasion; ± CFR for skull base/anterior cranial fossa extension"],
    ["T4b", "Generally unresectable; primary chemoradiation or induction chemotherapy → reassess resectability"],
]
story.append(table(max_surg, [2*cm, 13.6*cm]))
story.append(Spacer(1,8))

story.append(Paragraph("B. Nasal Cavity", h2))
story.append(rule())
nc_surg = [
    ["Stage", "Surgical Procedure"],
    ["T1", "Endoscopic resection (partial ethmoidectomy or nasal resection); lateral rhinotomy for anterior lesions"],
    ["T2", "Open medial maxillectomy or extended endoscopic resection depending on subsite"],
    ["T3", "Medial maxillectomy + orbital floor/medial wall resection; combined endoscopic-open for cribriform involvement"],
    ["T4a", "Craniofacial resection ± orbital exenteration"],
    ["T4b", "Unresectable; primary chemoradiation ± palliative surgery"],
]
story.append(table(nc_surg, [2*cm, 13.6*cm]))
story.append(Spacer(1,8))

story.append(Paragraph("C. Ethmoid Sinus", h2))
story.append(rule())
eth_surg = [
    ["Stage", "Surgical Procedure"],
    ["T1", "Endoscopic total ethmoidectomy"],
    ["T2", "Extended endoscopic ethmoidectomy ± medial maxillectomy"],
    ["T3", "CFR (limited: ethmoid + cribriform) or endoscopic endonasal skull base resection at expert centres; medial orbital wall resection if indicated"],
    ["T4a", "CFR with orbital exenteration for anterior orbital contents; extended endoscopic at expert centres"],
    ["T4b", "Unresectable; primary chemoradiation"],
]
story.append(table(eth_surg, [2*cm, 13.6*cm]))

# XII. NECK MANAGEMENT
story.append(Paragraph("XII. Neck Management", h1))
story.append(h1rule())
story.append(Paragraph(
    "Regional lymph node metastasis is uncommon at presentation (10–30%) but cervical failure "
    "contributes significantly to poor outcomes. Elective neck treatment is recommended for:",
    body))
story += bullets([
    "High-risk histologies (SCC, undifferentiated carcinoma)",
    "T3–T4 primary tumours",
    "Ipsilateral levels I–III most commonly at risk",
    "Therapeutic neck dissection (selective or comprehensive) for clinically positive nodes",
])

# XIII. RECONSTRUCTION
story.append(PageBreak())
story.append(Paragraph("XIII. Reconstruction", h1))
story.append(h1rule())

story.append(Paragraph("Brown-Shaw Classification of Maxillectomy Defects", h2))
story.append(rule())
story.append(Paragraph(
    "<b>Vertical (numbered I–VI):</b> I = no oronasal fistula → IV = orbital exenteration → "
    "V = orbitomaxillary → VI = nasomaxillary. "
    "<b>Horizontal (lettered A–D):</b> A = palate only → D = >half maxillectomy.",
    body))
story.append(Spacer(1,4))

recon_data = [
    ["Defect Class", "Reconstruction Options"],
    ["I–IIb (≤ half lateral alveolus/palate)", "Obturator OR radial forearm fasciocutaneous free flap"],
    ["III (orbital support needed)", "Fibula free flap (bone + soft tissue) or scapular free flap"],
    ["IV (with orbital exenteration)", "Rectus abdominis or anterolateral thigh (ALT) free flap; prosthetic eye"],
    ["Skull base (after CFR)", "Pericranial flap (turned-down vascularised flap)"],
    ["Skull base (after EEA)", "Nasoseptal (Hadad-Bassagastellys) flap"],
]
story.append(table(recon_data, [5.8*cm, 9.8*cm]))
story.append(Spacer(1,6))
story.append(Paragraph(
    "Microvascular free flap reconstruction is the standard of care for complex defects: "
    "it restores facial contour, supports the orbital floor, accepts dental implants, and "
    "withstands postoperative radiation. Speech intelligibility and swallowing outcomes are "
    "superior to obturation for palatal defects involving >50% of the palate.",
    body))

# XIV. SPECIAL CONSIDERATIONS
story.append(Paragraph("XIV. Special Considerations", h1))
story.append(h1rule())

story.append(Paragraph("Orbital Preservation Decision", h2))
story.append(rule())
story += bullets([
    "<b>Preserve globe if:</b> periorbita (orbital periosteum) is intact despite bony wall destruction — postoperative radiation covers residual microscopic disease",
    "<b>Exenterate if:</b> periorbita breached with infiltration of orbital fat or extraocular muscles; optic nerve involvement; decreased preoperative visual acuity",
])
story.append(Spacer(1,4))

story.append(Paragraph("Perineural Invasion (PNI)", h2))
story.append(rule())
story += bullets([
    "Most commonly affected nerves (in order): V2 (maxillary), hypoglossal, V3, facial nerve",
    "Mandates wider resection along the nerve back to the Gasserian ganglion for V2/V3",
    "MRI findings: widened neural foramina, enhancement, loss of fat planes around named nerves",
    "Associated with 3-fold increase in locoregional recurrence",
])
story.append(Spacer(1,4))

story.append(Paragraph("Unresectability Criteria", h2))
story.append(rule())
story += bullets([
    "Bilateral orbital apex involvement (bilateral blindness)",
    "Brain parenchyma invasion beyond the dura",
    "Carotid artery encasement",
    "Clivus or nasopharyngeal prevertebral muscle involvement (prevertebral fascia fixation)",
    "Bilateral cavernous sinus involvement",
], style=bul, marker="✕")

# XV. SUMMARY TABLE
story.append(Paragraph("XV. Summary: Approach Selection at a Glance", h1))
story.append(h1rule())
summary_data = [
    ["Approach", "Indication", "T-Stage Range"],
    ["Caldwell-Luc (sublabial)", "Small anteroinferior maxillary/alveolar lesions", "T1–T2 (limited)"],
    ["Lateral rhinotomy", "Nasal cavity, medial maxilla without orbit/palate involvement", "T1–T2"],
    ["Medial maxillectomy (open)", "Lateral nasal wall, ethmoid, medial maxilla", "T1–T2"],
    ["Infrastructural maxillectomy", "Alveolus, hard palate, inferior antrum", "T2"],
    ["Subtotal maxillectomy", "Extensive antrum, sparing orbital floor", "T2–T3"],
    ["Total maxillectomy", "Antrum + orbital floor invasion", "T3"],
    ["Total maxillectomy + exenteration", "Anterior orbital contents invaded", "T4a"],
    ["Craniofacial resection (CFR)", "Cribriform/anterior skull base, ethmoid", "T3–T4a"],
    ["Endoscopic (EEA)", "Medial/superior disease, no soft tissue extension", "T1–T3 (select)"],
    ["Chemoradiation (primary)", "Unresectable disease", "T4b"],
]
story.append(table(summary_data, [4.2*cm, 7*cm, 4.4*cm]))

# References
story.append(Paragraph("References", h1))
story.append(h1rule())
refs = [
    "Cummings Otolaryngology Head and Neck Surgery, 7th ed., Chapter 94 — Paranasal Sinus Cancer and Skull Base Surgery (pp. 1735–1760)",
    "K.J. Lee's Essential Otolaryngology, 10th ed. — Skull Base Malignancies (pp. 593–600)",
    "AJCC Cancer Staging Manual, 8th Edition — Nasal Cavity, Maxillary Sinus, and Ethmoid Sinus",
    "Brown JS, Shaw RJ. Reconstruction of the maxilla and midface: introducing a new classification. Lancet Oncol. 2010;11:1001–1008",
    "Ohngren LG. Malignant tumours of the maxillo-ethmoidal region. Acta Otolaryngol Suppl. 1933;19:1–476",
]
for i, r in enumerate(refs, 1):
    story.append(Paragraph(f"{i}.  {r}", ref_style))

story.append(Spacer(1, 0.5*cm))
story.append(HRFlowable(width="100%", thickness=1, color=NAVY, spaceAfter=6))
story.append(Paragraph("<i>Generated by Orris Medical Assistant · May 2026</i>", footer_style))

doc.build(story)
print(f"PDF saved: {OUTPUT}")
Running Command

python /home/daytona/workspace/sinonasal-surgery/generate_pdf.py

Your PDF is ready:

Sinonasal Surgery TNM

PDF Document · PDF

The document covers all 15 sections across ~6 pages with full formatting:
  • TNM staging tables for maxillary sinus, nasal cavity, and ethmoid sinus (AJCC 8th ed.)
  • Open vs. endoscopic comparison table
  • Step-by-step surgical techniques — Caldwell-Luc, lateral rhinotomy, medial maxillectomy, infrastructural/subtotal/total maxillectomy, orbital exenteration, craniofacial resection, and endoscopic EEA
  • Stage-specific decision tables for each subsite
  • Reconstruction guide (Brown-Shaw classification)
  • Unresectability criteria, orbital preservation decision points, and PNI management
  • Summary at-a-glance table and references
This is a shared conversation. Sign in to Orris to start your own chat.